SCHEMBL7250581

SCHEMBL7250581

O=C1C(=Cc2cccc(Cl)c2)SC(c2cccc(F)c2)N1CCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 12/20 0.47
DRD4 P21917 16/20 0.44
HTR1A P08908 11/20 0.44
HTR2A P28223 11/20 0.44
DRD3 P35462 10/20 0.44
HTR2C P28335 7/20 0.44
DRD2 P14416 13/20 0.44
SLC6A4 P31645 2/20 0.44
ADRA2C P18825 2/20 0.42
DRD1 P21728 2/20 0.42
DRD5 P21918 2/20 0.42
HRH1 P35367 2/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7250578 1.00 HTR7 (0.47) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7254175 0.98 HTR7 (0.46) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7254177 0.98 HTR7 (0.46) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7254858 0.95 HTR7 (0.49) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7254856 0.95 HTR7 (0.49) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7252865 0.94 DRD4 (0.47) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7252863 0.94 DRD4 (0.47) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7248928 0.94 HTR7 (0.49) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7248930 0.94 HTR7 (0.49) HTR7DRD4HTR1AHTR2ADRD3
SCHEMBL7248634 0.92 HTR1A (0.41) HTR7DRD4HTR1AHTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US claimed